Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 5’-deiodinase enzymes (D1, D2, and D3) are a family of selenoproteins that regulate thyroid hormone activity by catalyzing the removal of iodine atoms from thyroid hormones. D1 and D2 activate T4 to T3, while D3 inactivates T4 and T3. This regulation is crucial for maintaining tissue-specific levels of active thyroid hormone and for developmental control. Alterations in these enzymes can disrupt thyroid hormone homeostasis, leading to disorders such as hypothyroidism/hyperthyroidism or abnormal neurodevelopment.
Inhibition of deiodinase activity, reducing T3 production or increasing T4/T3 levels depending on the isoform and context.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5’-Deiodinase Enzyme.